TNFSF10 and Hodgkins lymphoma: When comparing subjects with non-relapsed disease (n = 47) to those with relapsed disease (n = 9, follow-up: 2–6 years), TNFSF10 was the only cytokine elevated among those with relapsed HL (3.03-fold) (Figure 1d and Table S3d).